Search by Drug Name or NDC
NDC 62135-0340-53 Sodium Polystyrene Sulfonate 4.1 meq/g Details
Sodium Polystyrene Sulfonate 4.1 meq/g
Sodium Polystyrene Sulfonate is a ORAL; RECTAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is SODIUM POLYSTYRENE SULFONATE.
Product Information
| NDC | 62135-0340 |
|---|---|
| Product ID | 62135-340_06fcec70-ae79-a194-e063-6394a90a6ffa |
| Associated GPIs | |
| GCN Sequence Number | 001194 |
| GCN Sequence Number Description | sodium polystyrene sulfonate POWDER ORAL |
| HIC3 | C1A |
| HIC3 Description | ELECTROLYTE DEPLETERS |
| GCN | 02890 |
| HICL Sequence Number | 013209 |
| HICL Sequence Number Description | SODIUM POLYSTYRENE SULFONATE |
| Brand/Generic | Generic |
| Proprietary Name | Sodium Polystyrene Sulfonate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sodium Polystyrene Sulfonate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER, FOR SUSPENSION |
| Route | ORAL; RECTAL |
| Active Ingredient Strength | 4.1 |
| Active Ingredient Units | meq/g |
| Substance Name | SODIUM POLYSTYRENE SULFONATE |
| Labeler Name | Chartwell RX, LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206815 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0340-53 (62135034053)
| NDC Package Code | 62135-340-53 |
|---|---|
| Billing NDC | 62135034053 |
| Package | 453.6 g in 1 BOTTLE (62135-340-53) |
| Marketing Start Date | 2022-07-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |